Veracyte: Q3 Earnings Insights
Portfolio Pulse from Benzinga Insights
Veracyte (NASDAQ:VCYT) reported its Q3 earnings results, missing estimated earnings by 173.33% with an EPS of $-0.41 versus an estimate of $-0.15. However, revenue was up $14.52 million from the same period last year. Last quarter, the company beat on EPS by $0.02, which was followed by a 7.04% increase in the share price the next day.
November 07, 2023 | 9:35 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Veracyte's Q3 earnings missed estimates significantly, which could negatively impact the stock price. However, the increase in revenue and past performance of share price increase following earnings beat could mitigate this impact.
Veracyte's significant earnings miss could lead to a decrease in investor confidence and a potential drop in the stock price. However, the company's increased revenue and history of share price increase following earnings beat could offset this negative impact.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100